# KryoNex Research

KryoNex Research is a technical research publication focused on reference
architectures, engineering frameworks, and evidence-based analysis across
AI, Industrial IoT, Enterprise Architecture, Intelligent Automation,
Supply Chain Technology, and Digital Transformation.

Published through **KryoNex Research**.

Website: https://kryonex.live  
Research: https://kryonex.live/research

Read `MANIFESTO.md` first. It defines the principles, research boundaries,
and editorial position of this repository and acts as the tiebreaker whenever
a publication's scope, tone, evidence standard, or technical position is
unclear.

## Editorial Position

KryoNex Research publishes reference architectures, frameworks, technical
notes, engineering guides, white papers, and evidence-based technical
analysis.

The research is not product marketing.

Publications should:

- remain technically defensible and evidence-aware;
- distinguish external facts from architectural synthesis;
- distinguish standards capability from regulatory requirements;
- avoid unsupported adoption, performance, or universality claims;
- preserve vendor neutrality unless a publication explicitly studies a
  particular technology or implementation;
- document important limitations and validation boundaries;
- maintain traceable evidence and publication provenance.

The objective is to produce durable technical work that architects,
engineers, researchers, technical leaders, and decision-makers can evaluate,
reference, and cite.

---

## Published Research

### RA-001 — Building Trust Across the Pharmaceutical Supply Chain

**A Reference Architecture for End-to-End Traceability**

| Field | Value |
|---|---|
| Research ID | RA-001 |
| Type | Reference Architecture |
| Author | A. S. Tomar |
| Affiliation | KryoNex |
| Publisher | KryoNex Research |
| Version | 1.0 |
| Publication Date | 27 July 2026 |
| Status | Published |

RA-001 presents a vendor-neutral reference architecture for
cross-organizational pharmaceutical traceability.

It examines pharmaceutical identification, serialization, GS1 EPCIS
traceability events, enterprise and regulatory systems, environmental
observations, organizational authority, evidence integrity, and trust
boundaries across multi-party pharmaceutical supply chains.

The architecture does not prescribe blockchain, distributed ledgers, IoT,
verifiable credentials, or any other individual technology as a universal
requirement. Technologies are evaluated according to the assurance problem,
governance model, regulatory environment, interoperability requirements,
and implementation context.

**Canonical publication**

https://kryonex.live/research/ra-001-pharmaceutical-supply-chain-traceability

**Publication source and evidence**

`publications/RA-001/`

**Version 1.0 PDF**

`releases/RA-001/v1.0/RA-001-v1.0.pdf`

**Evidence register**

`publications/RA-001/sources/evidence-register.md`

**Citation metadata**

`CITATION.cff`

---

## Repository Structure

```text
MANIFESTO.md
    Research and editorial principles for KryoNex Research.

publications/
    Canonical research sources organized by publication ID.

    RA-001/
        draft.md
            Canonical manuscript source.

        sources/
            Publication-specific evidence tracking and source records.

        figures/
            Publication figures and approved publication assets.

        CHANGELOG.md
            Research and publication version history.

        review-notes.md
            Internal review record. Not a public publication artifact.

releases/
    Frozen publication artifacts organized by publication and version.

    RA-001/
        v1.0/
            RA-001-v1.0.pdf
            metadata.json
            checksums.txt

frameworks/
    Reusable research outputs such as:
        trust-models/
        maturity-models/
        decision-matrices/
        implementation-patterns/

research-log/
    Dated research sessions and exploratory research records.

    Research exploration happens here before material is promoted into
    canonical publication content.

diagrams/
    Shared or reusable diagram assets not owned by a single publication.

references/
    Shared citation resources, standards references, and research material.

templates/
    Controlled templates for future research publications and reviews.

    research-publication/
        README.template.md
        draft.template.md
        CHANGELOG.template.md
        review-notes.template.md
        evidence-register.template.md

    checklists/
        technical-review.md
        publication-release.md
        website-sync.md
        live-verification.md

images/
    Shared research/publication brand assets.

editorial/
    Editorial standards and research publication guidance.

checklists/
    Repository-level review, publication, SEO, and discoverability controls.

CITATION.cff
    Machine-readable repository citation metadata.
